Olfactory impairment is common in Parkinson's disease.
Lower UPSIT score was associated with more severe non-motor symptoms.
Worse olfaction was associated with a greater decline in MoCA score.
Addition of AD CSF biomarkers to olfaction may improve ability to predict MCI.